comparemela.com

Latest Breaking News On - Carlos santos gallego - Page 1 : comparemela.com

Merck Drug for Rare Form of High Blood Pressure Gets US Nod

Merck Drug for Rare Form of High Blood Pressure Gets US Nod
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesAcceleron pharmaCarlos santos gallegoRob davisEvan seigermanRobert langrethUnited therapeutics corpDrug administrationIcahn school of medicine at mount sinaiBristol myers squibb coBloomberg merck coTherapeutics corpIcahn schoolMount sinaiChief executive officer rob davisNew england journal

DAPA-MI: Cardiometabolic Endpoints Win With Dapagliflozin After Acute MI

(UPDATED) The trial had to switch out its hard primary endpoints for a win-ratio analysis: the result was a “soft positive,” one observer said.

United statesNew yorkUppsala lanUnited kingdomLos angelesJonas oldgrenCarlos santos gallegoMichelle kittlesonStefan jamesPhd uppsala universityAmerican heart associationUppsala universityIcahn schoolMount sinai

STELLAR, Impressive Results With Novel Drug Sotatercept in PAH

The randomized trial of this first-in-class injectable drew sustained applause at ACC 2023 when results were presented.

New yorkUnited statesAnn arborCarlos santos gallegoMariusm hoeperGeoffrey barnesAcceleron pharmaRhondam cooperAmerican college of cardiology world congressMd hannover medical schoolWorld health organizationPharmd university of floridaMd universityHannover medical schoolAmerican collegeWorld congress

Some BP Meds Tied to Significantly Lower Risk for Dementia

Antihypertensive medications that stimulate type 2 and 4 angiotensin II receptors may reduce the rate of dementia compared with those that inhibit these receptors, new research suggests.

New yorkUnited statesCarlos santos gallegoHeather snyderZacharya marcumIcahn school of medicine at mount sinaiUniversity of washington school pharmacyAlzheimer associationWashington schoolMedscape medicalSystolic blood pressure intervention trialMedscape medical newsIcahn schoolMount sinaiNew york cityErebrovascular accident

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

HF hospitalizations were reduced in all patients, yet only the higher-risk diabetic patients gained the survival advantage.

New yorkUnited statesAl qalyubiyahCarlos santos gallegoBoehringer ingelheim eli lillyAhmed bendaryMd benha universityEgyptian society of cardiologyBenha universityCrystal clear classAmerican journalEli lillyMerck sharpIcahn schoolMount sinaiEgyptian society

vimarsana © 2020. All Rights Reserved.